Frank D. Lee sold $133k of BHC
director at Bausch Health Companies Inc.. 24,456 shares at an average of $5.43, traded May 19, 2026, filed May 20, 2026.
Score components
- +15RoleDirector
- +11Trade size$133k at market
- +10Share of holdings soldSold 33% of holdings
- 0ClusterNo other insider selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -13.3%, 3m +25.3%, 6m -.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0000885590-26-000063, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| May 19, 2026 | SOpen-market sale Common Shares, No Par Value10b5-1 | -24,456 | $5.43 | $133k | 49,339 | May 20, 2026 |
Related signals
Other insiders at Bausch Health Companies Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 13Weak | Bausch Health Companies Inc. | Aimee J. Lenar President, US Pharma | $259k 36,827 shares | -10% | |
| 3Weak | Bausch Health Companies Inc. | Seana Carson EVP, General Counsel | $65k 11,276 shares | -1% | |
| 2Weak | Bausch Health Companies Inc. | Seana Carson EVP, General Counsel | $50k 8,388 shares | -1% | |
| 36Weak | BHCbuy Bausch Health Companies Inc. | Paulson & Co. Inc. owner | $16M 2,500,000 shares | +4% | |
| 5Weak | Bausch Health Companies Inc. | Seana Carson EVP, General Counsel | $98k 13,370 shares | -3% | |
| 30Weak | BHCsell Bausch Health Companies Inc. | Frank D. Lee director | $122k 15,912 shares | -18% | |
| 59Moderate | BHCbuy Bausch Health Companies Inc. | John Paulson director | $312M 34,721,118 shares | +96% | |
| 56Moderate | BHCbuy Bausch Health Companies Inc. | John Paulson director | $21M 3,243,049 shares | +10% | |
| 56Moderate | BHCbuy Bausch Health Companies Inc. | John Paulson director | $21M 3,564,059 shares | +12% | |
| 51Moderate | BHCbuy Bausch Health Companies Inc. | John Paulson director | $15M 2,788,608 shares | +11% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.